A comprehensive view of KelAda Pharmachem. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
KelAda Pharmachem kicks off PROSPLIGN project in Dublin; €3.4M project aims to identify and utilize bioactive potentials of lignin for applications in pharmaceuticals, cosmetics and fragrances sectors
Published:
March 15, 2024
by Renewable Carbon Initiative (RCI)
|
Ask us about our R&D/Patents market view